Equate Anticavity Oral Rinse
- Manufacturer
- Wal-Mart Stores, Inc.
- Effective date
- 2023-01-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 23:52:59
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Sodium fluoride 0.021%
(0.01% w/v fluoride ion)
OTC - PURPOSE SECTION
Purpose
Anticavity
INDICATIONS & USAGE SECTION
Use aids in the prevention of dental cavities
WARNINGS SECTION
Warnings
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children under 6 years of age. If more than used for rinsing is accidentally swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults and children 6 years and older: use twice a day after brushing your teeth with a toothpaste
- vigorously swish 10 mL (2 teaspoonfuls) of rinse between your teeth for 1 minute and then spit out.
- do not swallow the rinse
- do not eat or drink for 30 minutes after rinsing
- instruct children under 12 years of age in good rinsing habits (to minimize swallowing)
- supervise childrenas necessary until capable of using without supervision
- children under 6 years of age: consult a dentist or doctor
INACTIVE INGREDIENT SECTION
Inactive ingredients water, glycerin, flavor, cetylpyridinium chloride, poloxamer 407, phosphoric acid, methylparaben, sodium saccharin, propylparaben, propylene glycol, disodium phosphate, red 33, green3
OTC - QUESTIONS SECTION
Questions? Call 1-888-287-1915
SPL UNCLASSIFIED SECTION
DISTRIBUTED BY: Wal-Mart Stores, Inc., Bentonville, AR 72716
PRODUCT OF CANADA
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
equate™
Anticavity Oral Rinse
Multi-Action with Fluoride
33.8 FL OZ (1L)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49035-535-86 | 2025-01-30 | C162847 | 48780-1 | c7ccaba7-24db-fd44-e053-dadaa90aa01b | Equate Anticavity Oral Rinse |
| 49035-535-86 | 2021-08-23 | C162847 | 48780-1 | c7ccaba7-24db-fd44-e053-dadaa90aa01b | Equate Anticavity Oral Rinse |
| 49035-535-86 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-24db-fd44-e053-dadaa90aa01b | Equate Anticavity Oral Rinse |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49035-535-86 | Equate Anticavity Oral Rinse | 1000 mL in 1 BOTTLE, PLASTIC | LIQUID | 1000 | 4 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Equate Anticavity Oral Rinse
- Fluoride
- D&C RED NO. 33
- FD&C RED NO. 3
- WATER
- GLYCERIN
- CETYLPYRIDINIUM CHLORIDE
- POLOXAMER 407
- PHOSPHORIC ACID
- METHYLPARABEN
- SACCHARIN SODIUM
- PROPYLPARABEN
- PROPYLENE GLYCOL
- SODIUM PHOSPHATE, DIBASIC
- SODIUM FLUORIDE
- FLUORIDE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49035-535 | 49035-535-86 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| D&C RED NO. 33 | 9DBA0SBB0L | IACT |
| FD&C RED NO. 3 | PN2ZH5LOQY | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| CETYLPYRIDINIUM CHLORIDE | D9OM4SK49P | IACT |
| POLOXAMER 407 | TUF2IVW3M2 | IACT |
| PHOSPHORIC ACID | E4GA8884NN | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | IACT |
| SODIUM FLUORIDE | 8ZYQ1474W7 | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f19e44c8-fb9c-57a7-e053-2a95a90afd7a | 45739013-5581-12bb-e054-00144ff88e88 | 2023-01-06 | Warnings | f19e44c8-fb9c-57a7-e053-2a95a90afd7a 45739013-5581-12bb-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
